Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | INPPL1 | O15357 | 3/20 | 0.52 |
| ▸ | INPP5A | Q14642 | 3/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | INPP5B | P32019 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | ACP3 | P15309 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31169481 | 1.00 | SRC (0.58) | SRCLMNAINPPL1INPP5AACHE | |
| Hydrochloric Acid SCHEMBL11751642 | 0.98 | SRC (0.56) | SRCLMNAINPPL1INPP5AACHE | |
| SCHEMBL3388030 | 0.88 | LMNA (0.53) | SRCLMNAACHEMAPTHTT | |
| SCHEMBL30529849 | 0.88 | LMNA (0.53) | SRCLMNAACHEMAPTHTT | |
| SCHEMBL29758988 | 0.88 | LMNA (0.53) | SRCLMNAACHEMAPTHTT | |
| SCHEMBL130697 | 0.85 | INPPL1 (0.71) | SRCINPPL1INPP5AKMT2AINPP5B | |
| SCHEMBL10838769 | 0.85 | LMNA (0.50) | SRCLMNAACHEMAPTHTT | |
| SCHEMBL187081 | 0.83 | ALDH1A1 (0.61) | LMNAACHEMAPTHTTL3MBTL1 | |
| SCHEMBL29790831 | 0.83 | ALDH1A1 (0.61) | LMNAACHEMAPTHTTL3MBTL1 | |
| Phosphoric Acid SCHEMBL28992406 | 0.83 | INPPL1 (0.68) | SRCINPPL1INPP5AKMT2AINPP5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008091135-A1 | CONDUCTIVE POLYMER COMPOSITION FOR RADIOGRAPHIC IMAGING | ELPANI CO., LTD. (KR) | 2008-07-31 | — | — | WO | claimed |
| CN-116745025-A | membrane for water filtration | 水通道蛋白有限公司 | 2023-09-12 | — | — | CN | disclosed |
| CN-112930383-B | Composition, film, laminated structure, light-emitting device, and display | 住友化学株式会社 | 2023-09-08 | — | — | CN | disclosed |
| CN-113583042-B | Preparation method of phosphoryl fluoride compound | 烟台大学 | 2023-08-29 | — | — | CN | disclosed |
| CN-111655818-B | Composition, film, laminate structure, light emitting device, and display | 住友化学株式会社 | 2023-05-09 | — | — | CN | disclosed |
| CN-113583042-A | Preparation method of phosphoryl fluoride compound | 烟台大学 | 2021-11-02 | — | — | CN | disclosed |
| WO-2021113686-A1 | MASP-2 INHIBITORS AND METHODS OF USE | OMEROS CORPORATION (US) | 2021-06-10 | — | — | WO | disclosed |
| WO-2019112930-A1 | ADHESIVE COMPOSITIONS AND METHODS | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2019-06-13 | — | — | WO | disclosed |
| US-9920083-B2 | Image recording paper medium and image recording method | FUJIFILM CORPORATION (JP) | 2018-03-20 | — | — | US | disclosed |
| US-20160250866-A1 | IMAGE RECORDING PAPER MEDIUM AND IMAGE RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2016-09-01 | — | — | US | disclosed |
| US-20150191490-A1 | MITOTIC KINESIN INHIBTORS AND METHODS OF USE THEREOF | ARRAY BIOPHARMA INC. (US) | 2015-07-09 | — | — | US | disclosed |
| US-8580828-B2 | Mitotic kinesin inhibitors and methods of use thereof | ARRAY BIOPHARMA INC. (US) | 2013-11-12 | — | — | US | disclosed |
| US-20130109656-A1 | MITOTIC KINESIN INHIBITORS AND METHODS OF USE THEREOF | ARRAY BIOPHARMA, INC. | 2013-05-02 | — | — | US | disclosed |
| US-8389638-B2 | Multifunctional additive grafted rubber and process for the preparation thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2013-03-05 | — | — | US | disclosed |
| EP-2168781-B1 | Heat-sensitive transfer sheet | FUJIFILM CORP (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-20090062474-A1 | NOVEL MULTIFUNCTIONAL ADDITIVE GRAFTED RUBBER AND PROCESS FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2009-03-05 | — | — | US | disclosed |
| WO-2008091135-A1 | CONDUCTIVE POLYMER COMPOSITION FOR RADIOGRAPHIC IMAGING | ELPANI CO., LTD. (KR) | 2008-07-31 | — | — | WO | disclosed |
| US-5679763-A | Polyquinoline-based nonlinear optical materials | ENICHEM S.P.A. (IT) | 1997-10-21 | — | — | US | disclosed |
| EP-0729056-A1 | Polyquinoline-based nonlinear optical materials | ENICHEM S.p.A. (IT) | 1996-08-28 | — | — | EP | disclosed |
| WO-1995012628-A1 | CONJUGATED POLYMER EXCIPLEXES AND APPLICATIONS THEREOF | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1995-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130109656-A1 | MITOTIC KINESIN INHIBITORS AND METHODS OF USE THEREOF | KIF5B, KIF2C, KIFC1 | SRC 2473/4885LMNA 1583/4885INPPL1 862/4885 |
| US-20150191490-A1 | MITOTIC KINESIN INHIBTORS AND METHODS OF USE THEREOF | KIF5B, KIF2C, KIFC1 | SRC 2999/4885LMNA 1419/4885INPPL1 986/4885 |
| US-20160250866-A1 | IMAGE RECORDING PAPER MEDIUM AND IMAGE RECORDING METHOD | PHOSPHO1, ITPR2, PPIP5K2 | SRC 636/4885LMNA 3055/4885INPPL1 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.